Assure Holdings PE Ratio 2020-2024 | IONM
Current and historical p/e ratio for Assure Holdings (IONM) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Assure Holdings PE ratio as of July 02, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Assure Holdings PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-02-10 | 0.00 | 0.00 | |
2024-06-30 | 7.61 | $-32.33 | 0.00 |
2024-03-31 | 8.82 | $-61.15 | 0.00 |
2023-12-31 | 4.59 | $-125.00 | 0.00 |
2023-09-30 | 3.89 | $-125.00 | 0.00 |
2023-06-30 | 17.10 | $-135.25 | 0.00 |
2023-03-31 | 59.76 | $-239.03 | 0.00 |
2022-12-31 | 93.71 | $-233.81 | 0.00 |
2022-09-30 | 230.40 | $-244.60 | 0.00 |
2022-06-30 | 525.60 | $-208.63 | 0.00 |
2022-03-31 | 1944.00 | $-111.51 | 0.00 |
2021-12-31 | 1944.00 | $-79.14 | 0.00 |
2021-09-30 | 2712.60 | $-86.33 | 0.00 |
2021-06-30 | 756.00 | $-143.89 | 0.00 |
2021-03-31 | 511.20 | $-773.38 | 0.00 |
2020-12-31 | 370.80 | $-773.38 | 0.00 |
2020-09-30 | 323.28 | $-755.40 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.000B | $0.000B |
Assure Holdings Corp. works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services which support intraoperative neuromonitoring activities during invasive surgeries. Assure Holdings Corp. is based in DENVER. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $143.921B | 26.99 |
Elevance Health (ELV) | United States | $89.416B | 11.54 |
CVS Health (CVS) | United States | $88.020B | 10.94 |
Cencora (COR) | United States | $57.242B | 19.91 |
DiDi Global (DIDIY) | China | $22.544B | 23.95 |
Labcorp Holdings (LH) | United States | $22.119B | 17.94 |
Natera (NTRA) | United States | $21.946B | 0.00 |
BioMerieux (BMXMF) | France | $16.861B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $14.094B | 0.00 |
Solventum (SOLV) | United States | $13.476B | 14.27 |
CochLear (CHEOY) | Australia | $12.827B | 0.00 |
ICON (ICLR) | Ireland | $12.023B | 11.18 |
Revvity (RVTY) | United States | $11.673B | 20.09 |
Viatris (VTRS) | United States | $10.774B | 3.70 |
Avantor (AVTR) | United States | $9.486B | 13.78 |
Medpace Holdings (MEDP) | United States | $9.228B | 24.51 |
HealthEquity (HQY) | United States | $8.897B | 38.97 |
Sonic Healthcare (SKHHY) | Australia | $8.498B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.583B | 14.86 |
Caris Life Sciences,�Inc (CAI) | $6.744B | 0.00 | |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.758B | 28.02 |
BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
Sotera Health (SHC) | United States | $3.250B | 18.47 |
Surgery Partners (SGRY) | United States | $2.890B | 37.58 |
Alignment Healthcare (ALHC) | United States | $2.811B | 0.00 |
Concentras Parent (CON) | United States | $2.671B | 15.44 |
Organon (OGN) | United States | $2.613B | 2.78 |
GeneDx Holdings (WGS) | United States | $2.576B | 99.22 |
PACS (PACS) | United States | $1.974B | 0.00 |
Ardent Health (ARDT) | United States | $1.964B | 8.37 |
Progyny (PGNY) | United States | $1.891B | 41.62 |
Premier (PINC) | United States | $1.789B | 13.58 |
GoodRx Holdings (GDRX) | United States | $1.772B | 35.43 |
Teladoc Health (TDOC) | United States | $1.505B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.255B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.231B | 9.37 |
CareDx (CDNA) | United States | $1.050B | 16.39 |
Agilon Health (AGL) | United States | $0.985B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.842B | 7.88 |
QDM (QDMI) | Hong Kong, SAR China | $0.776B | 0.00 |
Nutex Health (NUTX) | United States | $0.732B | 11.09 |
Embecta (EMBC) | United States | $0.600B | 4.04 |
LifeMD (LFMD) | United States | $0.597B | 0.00 |
InnovAge Holding (INNV) | United States | $0.533B | 0.00 |
SBC Medicals (SBC) | United States | $0.483B | 0.00 |
Omada Health (OMDA) | $0.470B | 0.00 | |
Auna S.A (AUNA) | Luxembourg | $0.466B | 10.48 |
Sonida Senior Living (SNDA) | United States | $0.456B | 0.00 |
Enhabit (EHAB) | United States | $0.399B | 32.83 |
Performant Healthcare (PHLT) | United States | $0.322B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.296B | 0.00 |
So-Young (SY) | China | $0.288B | 0.00 |
Beauty Health (SKIN) | United States | $0.272B | 0.00 |
Oncology Institute (TOI) | United States | $0.196B | 0.00 |
DocGo (DCGO) | United States | $0.155B | 25.33 |
Pheton Holdings (PTHL) | China | $0.121B | 0.00 |
Sera Prognostics (SERA) | United States | $0.098B | 0.00 |
KindlyMD (NAKA) | United States | $0.082B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.066B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
ModivCare (MODV) | United States | $0.045B | 0.00 |
Biodesix (BDSX) | United States | $0.042B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.030B | 0.00 |
OSR Holdings (OSRH) | United States | $0.029B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.020B | 0.00 | |
Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |